Russell Investments Group Ltd. increased its stake in Centene Corporation (NYSE:CNC – Free Report) by 22.1% during the third quarter, HoldingsChannel reports. The firm owned 2,627,529 shares of the company’s stock after acquiring an additional 475,603 shares during the period. Russell Investments Group Ltd.’s holdings in Centene were worth $163,257,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also bought and sold shares of the company. BlackRock Inc. purchased a new stake in Centene in the second quarter worth $2,660,422,000. Wellington Management Group LLP raised its stake in shares of Centene by 423.0% in the second quarter. Wellington Management Group LLP now owns 13,301,215 shares of the company’s stock valued at $853,805,000 after buying an additional 10,757,914 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Centene by 12.4% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,517,580 shares of the company’s stock valued at $354,173,000 after buying an additional 608,249 shares during the last quarter. Assenagon Asset Management S.A. lifted its position in shares of Centene by 21.6% during the 3rd quarter. Assenagon Asset Management S.A. now owns 4,518,785 shares of the company’s stock valued at $302,818,000 after buying an additional 802,756 shares during the last quarter. Finally, Bank of America Corp DE bought a new position in shares of Centene during the 2nd quarter worth $285,713,000. Hedge funds and other institutional investors own 93.63% of the company’s stock.
Insider Activity at Centene
In other news, General Counsel Christopher Koster sold 56,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $66.90, for a total value of $3,779,850.00. Following the completion of the transaction, the general counsel directly owned 248,854 shares in the company, valued at approximately $16,648,332.60. This trade represents a 18.50% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.37% of the company’s stock.
Centene Stock Performance
NYSE:CNC opened at $71.23 on Monday. The business’s fifty day moving average is $67.07 and its 200 day moving average is $56.51. The firm has a market cap of $35.27 billion, a price-to-earnings ratio of 24.40, a PEG ratio of 0.42 and a beta of 1.07. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.16 and a current ratio of 1.16. Centene Corporation has a 52-week low of $31.63 and a 52-week high of $78.08.
Centene (NYSE:CNC – Get Free Report) last issued its earnings results on Tuesday, October 27th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.10 by $0.48. The business had revenue of $50.65 billion during the quarter, compared to the consensus estimate of $47.12 billion. Centene had a return on equity of 12.15% and a net margin of 0.72%. The firm’s revenue was up 1.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.50 EPS. Research analysts predict that Centene Corporation will post 5.27 EPS for the current year.
Analysts Set New Price Targets
CNC has been the subject of several recent research reports. Wall Street Zen lowered Centene from a “strong-buy” rating to a “buy” rating in a report on Saturday, October 31st. HC Wainwright reaffirmed a “buy” rating on shares of Centene in a report on Friday, September 11th. Weiss Ratings upgraded shares of Centene from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, October 28th. Raymond James Financial set a $79.00 target price on shares of Centene in a research note on Wednesday, October 28th. Finally, Mizuho set a $72.00 price target on shares of Centene in a research report on Wednesday, October 28th. Nine research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $73.80.
Read Our Latest Research Report on CNC
Centene Company Profile
Centene Corporation is a U.S. health care company that provides managed care and related services, primarily for people enrolled in government-sponsored health programs. Its offerings include Medicaid and Medicare plans, as well as health insurance sold through the Affordable Care Act marketplace. Centene serves members through health plans and a network of health care providers. Its businesses include Ambetter, which offers marketplace health plans, and Wellcare, which provides Medicare-related coverage.
Further Reading
- Five stocks we like better than Centene
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
